Managing Asthma Patients with AMAZE™: A Novel Disease Management Platform

Trial Identifier:	N4280000000
Sponsor:	AstraZeneca
Collaborator:	Massachusetts General Hospital Evidera
NCTID::	NCT04868500
Start Date:	April 2021
Primary Completion Date:	November 2021
Study Completion Date:	November 2021
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, MA	Boston, MA, USA, 02114

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.